Literature DB >> 12555604

[Paper or screen, mother tongue or English--which is better?].

Pål Gulbrandsen1, Torben V Schroeder, Josef Milerad, Magne Nylenna.   

Abstract

BACKGROUND: The trends in medical publishing are towards electronic versions and the use of the English language. The objective of this study was to compare general practitioners' ability to retain information when reading on paper versus on screen, and in their mother tongue versus in the English.
MATERIAL AND METHODS: Randomized controlled trial of 114 Scandinavian general practitioners. They read a review article for 10 minutes either on paper/in English, on screen/in English, on paper/in their mother tongue, or on screen/in their mother tongue. Afterwards they completed a questionnaire with six open questions from the article. The main outcome measure was sum score on a scale from 0 (no correct answers) to 13 (all questions answered correctly).
RESULTS: We found no difference between readers of paper and screen versions (median (interquartile range) 4 (2-6) vs. 4 (2-5), p = 0.97). Those who read their mother tongue scored significantly higher than those who read English (4 (3-6) vs. 3 (2-4), p = 0.01).
INTERPRETATION: The medium (paper vs. screen) does not influence the ability of general practitioners to retain medical information. Doctors best retain medical information when reading it in their mother tongue.

Mesh:

Year:  2002        PMID: 12555604

Source DB:  PubMed          Journal:  Tidsskr Nor Laegeforen        ISSN: 0029-2001


  2 in total

1.  [Which Spanish journals are read and how Primary Care doctors keep informed].

Authors:  Javier González de Dios; Angeles Flores Canoura; Josep Jiménez Villa; José Antonio Gutiérrez Fuentes
Journal:  Aten Primaria       Date:  2011-06-02       Impact factor: 1.137

2.  Disadvantages in preparing and publishing scientific papers caused by the dominance of the English language in science: The case of Colombian researchers in biological sciences.

Authors:  Valeria Ramírez-Castañeda
Journal:  PLoS One       Date:  2020-09-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.